Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Boman

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
Thrombosis Research|September 19, 2009
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudyKurt Boman, Jan-Håkan Jansson, Torbjörn Nilsson, et al.
BMC Infectious Diseases|March 3, 2011
Prevalence of systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin in relation to the incidence of myocardial infarctionAnders Johansson, Marie Eriksson, Ann-Marie Ahrén, et al.
BMJ Open|December 20, 2015
Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990-2006Yulia Blomstedt, Margareta Norberg, Hans Stenlund, et al.
Journal of Cardiovascular Risk|October 24, 2002
Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic variables in plasma--a 2-year follow-up studyTorbjörn K Nilsson, J David Spence, Peter M Nilsson, et al.
Thrombosis Research|January 18, 2011
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversionJonas Andersson, Henrik Almroth, Niklas Höglund, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 17, 2009
Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern SwedenHans Grönlund, Göran Hallmans, Jan Håkan Jansson, et al.
Patient Education and Counseling|September 6, 2005
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trialInger Ekman, Gull Andersson, Kurt Boman, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 5, 2006
The effects of commuting activity and occupational and leisure time physical activity on risk of myocardial infarctionPatrik Wennberg, Bernt Lindahl, Göran Hallmans, et al.
American Journal of Hypertension|March 30, 2012
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophyEva Gerdts, Peter M Okin, Kurt Boman, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension StudyEva Gerdts, Peter M Okin, Giovanni de Simone, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Thrombosis Research|September 19, 2009
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudyKurt Boman, Jan-Håkan Jansson, Torbjörn Nilsson, et al.
BMC Infectious Diseases|March 3, 2011
Prevalence of systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin in relation to the incidence of myocardial infarctionAnders Johansson, Marie Eriksson, Ann-Marie Ahrén, et al.
BMJ Open|December 20, 2015
Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990-2006Yulia Blomstedt, Margareta Norberg, Hans Stenlund, et al.
Journal of Cardiovascular Risk|October 24, 2002
Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic variables in plasma--a 2-year follow-up studyTorbjörn K Nilsson, J David Spence, Peter M Nilsson, et al.
Thrombosis Research|January 18, 2011
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversionJonas Andersson, Henrik Almroth, Niklas Höglund, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 17, 2009
Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern SwedenHans Grönlund, Göran Hallmans, Jan Håkan Jansson, et al.
Patient Education and Counseling|September 6, 2005
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trialInger Ekman, Gull Andersson, Kurt Boman, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 5, 2006
The effects of commuting activity and occupational and leisure time physical activity on risk of myocardial infarctionPatrik Wennberg, Bernt Lindahl, Göran Hallmans, et al.
American Journal of Hypertension|March 30, 2012
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophyEva Gerdts, Peter M Okin, Kurt Boman, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension StudyEva Gerdts, Peter M Okin, Giovanni de Simone, et al.
Pageof 18